The HRF, Inc. has been majority owned and operated by individuals with coagulation disorders since its inception in 1985. The owners are employees or partners with a lifetime of hemophilia care, coagulation clinical experience, plasmapheresis collection experience and who may also live with a bleeding or clotting disorder. The company was founded with three basic mission principles:
HRF, Inc. is a US Licensed, FDA Regulated Source Plasma Center that provides rare specialty Human Blood Plasma for the International Market (non-injectable) for Manufacture into InVitro Diagnostic Products, Research and Development of Clotting Concentrates and as an Aid in the Search for a Cure for Hemophilia and Other Coagulation Disorders through Genetic Discovery.